This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Dominion Diagnostics To Sponsor 2013 Addiction Professional Panel Series As Thought Leadership Partner

NORTH KINGSTOWN, R.I., March 26, 2013 /PRNewswire/ -- Dominion Diagnostics, a leading national provider of clinical drug testing and medication monitoring services, will sponsor a year-long series of regional educational Lunch'n'Learns hosted by Addiction Professional, a magazine published for the addiction treatment field by Vendome Healthcare Media.

Dominion Diagnostics has been designated by Addiction Professional as a Thought Leadership Partner for 2013.  As a lead sponsor and designated partner, Dominion will participate in each event in the educational series.  Each panel in the series will feature thought leaders and experts from the addiction treatment and behavioral health fields discussing critical topics in managing addiction treatment today.

A number of the 2013 series featured panelists are members of Dominion's Addiction Medicine Advisory Board, an assembly of 14 recognized thought leaders with vast experience in the addiction medicine field. The Board focuses on collaborative research, developing and delivering educational curricula, and understanding field trends to assist Dominion in designing clinically relevant products and services for addiction treatment providers. 

"For more than 16 years, Dominion Diagnostics has demonstrated an ongoing commitment to the recovery community and a dedication to advancing patient care and improving outcomes by supporting treatment with state-of-the-art laboratory science," said David E. Smith, MD of San Francisco, California. "Dominion is the precise thought leadership partner to promote education for addiction treatment providers in the field today." 

Dr. Smith is well-known in the field for establishing the Haight-Ashbury Free Medical Clinics in 1967. Dr. Smith is also a past president of the American Society of Addiction Medicine, a current participant in the San Francisco Medical Society Committee on the Well-Being of Physicians, and a member of Dominion's Addiction Medicine Advisory Board.

The 2013 Addiction Professional Panel Series, which will include up to nine lunch and learn educational events, will kick off in March with programs in Dallas, Texas ( March 27) and Anaheim, California ( March 28).  The panel discussion topic for both March events is Building a Recovery-Oriented System of Care.    

Registration is now open at:

About Dominion Diagnostics

Dominion Diagnostics is a leading national provider of clinical drug testing, medication monitoring services, and a full suite of clinical support solutions. Since 1997, Dominion Diagnostics has provided services to thousands of clients representing a diversity of medical specialties across the United States, including addiction medicine, behavioral health, pain medicine, primary care, psychiatry, and hospital systems. Dominion Diagnostics is supported by a world-class team that shares a commitment to clinical excellence, compliance, and integrity. For more information, please visit

About Addiction Professional

Addiction Professional's mission is to assist counselors, medical staff, supervisors, and other key decision makers at addiction treatment and prevention organizations in their pursuit of clinical excellence. Reporting on the whole spectrum of addictions and addiction treatment services, Addiction Professional provides timely guidance on care delivery, management strategies, and emerging trends affecting addiction services in the public and private sectors.  Addiction Professional is part of group of high-quality publications published by Vendome Healthcare Media for professionals in the Behavioral Health and Addiction Treatment fields.  Additional, Vendome produces the National Conference on Addiction Disorders each September, a premiere event that aims to supply both clinical and managerial strategies designed to improve the quality of life for addiction treatment and behavioral health patients. For more information, please visit

Media contact: Leigh Melanson, 401-667-0837, 

SOURCE Dominion Diagnostics, LLC

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,812.19 +19.51 0.11%
S&P 500 2,089.14 +2.55 0.12%
NASDAQ 5,102.8080 +0.33 0.01%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs